PfVP1, a battery of the malaria parasite, is critical for ring stage development
PfVP1, a battery of the malaria parasite, is critical for ring stage development
批准号:
10300573
负责人:
Hangjun Ke
金额:
$18.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-11-10 至 2023-10-31
关键词:
AffinityAntimalarialsArchaeaBacteriaBiochemicalBioenergeticsBiologicalBiologyBloodBudgetsCRISPR/Cas technologyCell membraneCellsComplementConsumptionContractsDNA biosynthesisDataDevelopmentDiphosphatesDrug resistanceEnergy SupplyEnergy-Generating ResourcesErythrocytesFutureGeneticGlucoseGlycolysisHumanHydrolysisKnock-outMalariaMammalian CellMeasuresMediatingMembraneMetabolicMolecular TargetMutagenesisMutateNutrientOrganismOxidative PhosphorylationParasitesPersonsPhysiologicalPlantsPlasmodium falciparumProcessProteinsProton PumpProtonsRNAReactionRegulatory ElementResistanceResistance developmentRiskRoleRouteRunningSaccharomyces cerevisiaeTestingTimeVacuoleVesicleWaste ProductsYeastsasexualbasecostdrug developmentfungusgenomic locusglobal healthinsightknock-downmetabolic ratenutritionpyrophosphatasesodium ionuptake
中文摘要
项目摘要
疟疾仍然是一个主要的全球健康问题,控制进展遇到了严重的问题,
近年来的瓶颈。每年有超过30亿人生活在感染的风险中,
有2亿人感染疟疾,50万人死于疟疾。疟疾
寄生虫迅速对现有的抗疟药物产生耐药性,
基础生物学是迫切需要的。在无性血液阶段,疟原虫主要
回答糖酵解的能量,因为寄生虫的寄生虫不进行氧化
磷酸化产生ATP。它们还包含膜结合质子泵
焦磷酸酶(mPPases),它使用焦磷酸盐,超过200个细胞的副产物,
反应,作为能量源泵质子穿过膜。我们先前已经
敲除PfVP 2(PF3D7_1235200),而预测为PfVP 1(PF3D7_1456800)
是必不可少的。使用CRISPR/Cas9介导的遗传标记/条件性敲低,
已经发现PfVP 1定位于寄生虫质膜,并且是环
阶段发展。在本申请中,我们假设PfVP 1使用焦磷酸作为
替代能源以维持环级中的质子电化学梯度
恶性疟原虫的发展。我们将在以下目标中检验这一假设。
目的1、研究PfVP 1作为膜质子泵焦磷酸酶的活性。
目的2、明确PfVP 1在环期寄生虫中的功能。这项提案将揭示
环阶段发展和生物能量学的重要见解,关键但未充分研究
寄生虫生物学的各个方面。如果成功,这里提出的研究将提供直接证据,
替代能源对于疟疾寄生虫的早期发展至关重要,
红细胞。在环阶段找到关键的分子靶点也将有助于靶向药物的开发。
未来的发展,以更好地抑制代谢活性较低的寄生虫形式,
对目前的抗疟药有抗药性。
英文摘要
Project Summary
Malaria remains a major global health concern and the control progress has run into a serious
bottleneck in recent years. Each year, more than 3 billion people are living at risk of contracting
malaria, 200 million people are infected and half a million people die from malaria. As malaria
parasites rapidly develop resistance to available antimalarial drugs, a better understanding of
fundamental biology is urgently needed. In the asexual blood stages, malaria parasites mainly
reply on glycolysis for energy since the parasite's mitochondrion does not perform oxidative
phosphorylation to produce ATP. They also contain membrane bound proton pumping
pyrophosphatases (mPPases), which use pyrophosphate, the by-product of over 200 cellular
reactions, as the energy source to pump protons across a membrane. We have previously
knocked out PfVP2 (PF3D7_1235200) whereas PfVP1 (PF3D7_1456800) has been predicted
to be essential. Using a CRISPR/Cas9 mediated genetic tagging/conditional knockdown, we
have found that PfVP1 is localized to the parasite plasma membrane and is essential for ring
stage development. In this application, we hypothesize that PfVP1 uses pyrophosphate as an
alternative energy source to sustain a proton electrochemical gradient in the ring stage
development of Plasmodium falciparum. We will test this hypothesis in the following aims.
Aim 1, Assess the activity of PfVP1 as an integral membrane proton-pumping pyrophosphatase.
Aim 2, Define the function of PfVP1 in ring stage parasites. Together, this proposal will uncover
important insights of ring stage development and bioenergetics, critical yet understudied
aspects of parasite biology. If successful, the studies proposed here will provide direct evidence
that an alternative energy source is critical for early stage development of a malaria parasite in
RBCs. Finding a critical molecular target at the ring stage will also facilitate target-based drug
development in future to better inhibit metabolically less active parasite forms that are often
resistant to current antimalarials.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.ppat.1011818
发表时间:
2023-12
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[]
通讯作者:
PfVP1, a battery of the malaria parasite, is critical for ring stage development
-
批准号:10116730
-
项目类别:
-
资助金额:$22.56万
-
财政年份:2020
-
负责人:Hangjun Ke
-
依托单位:
Nonconventional mitochondrial ribosomes of malaria parasites
-
批准号:9537410
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2017
-
负责人:Hangjun Ke
-
依托单位:
Nonconventional mitochondrial ribosomes of malaria parasites
-
批准号:9222483
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2017
-
负责人:Hangjun Ke
-
依托单位:
海外基金